These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 25721211)
1. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells. Zhao Z; Zhang L; Yao Q; Tao Z Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211 [TBL] [Abstract][Full Text] [Related]
2. miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells. Li J; Wang Y; Song Y; Fu Z; Yu W Mol Cancer; 2014 Aug; 13():193. PubMed ID: 25128483 [TBL] [Abstract][Full Text] [Related]
3. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910 [TBL] [Abstract][Full Text] [Related]
4. miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1. Li J; Li S; Chen Z; Wang J; Chen Y; Xu Z; Jin M; Yu W Tumour Biol; 2016 Oct; 37(10):13287-13294. PubMed ID: 27460077 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells. Yu G; Zhong N; Chen G; Huang B; Wu S Tumour Biol; 2014 Oct; 35(10):10341-9. PubMed ID: 25038915 [TBL] [Abstract][Full Text] [Related]
6. miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin. Chen X; Jiang Y; Huang Z; Li D; Chen X; Cao M; Meng Q; Pang H; Sun L; Zhao Y; Cai L Sci Rep; 2016 Jan; 6():19455. PubMed ID: 26781643 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Feng B; Wang R; Song HZ; Chen LB Cancer; 2012 Jul; 118(13):3365-76. PubMed ID: 22139708 [TBL] [Abstract][Full Text] [Related]
8. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Sun L; Yao Y; Liu B; Lin Z; Lin L; Yang M; Zhang W; Chen W; Pan C; Liu Q; Song E; Li J Oncogene; 2012 Jan; 31(4):432-45. PubMed ID: 21725369 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C. Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956 [TBL] [Abstract][Full Text] [Related]
10. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway. Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754 [TBL] [Abstract][Full Text] [Related]
11. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992 [TBL] [Abstract][Full Text] [Related]
12. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma. Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells. Li H; Zhang P; Sun X; Sun Y; Shi C; Liu H; Liu X Int J Oncol; 2015 Oct; 47(4):1379-92. PubMed ID: 26323677 [TBL] [Abstract][Full Text] [Related]
14. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998 [TBL] [Abstract][Full Text] [Related]
15. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Feng B; Wang R; Chen LB Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675 [TBL] [Abstract][Full Text] [Related]
16. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8. Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of miR-15b partially reverses the cisplatin resistance of NSCLC through the GSK-3β/MCL-1 pathway. Lu T; Lu W; Jia C; Lou S; Zhang Y Adv Clin Exp Med; 2021 Aug; 30(8):849-857. PubMed ID: 34286518 [TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway. Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075 [TBL] [Abstract][Full Text] [Related]
19. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Zhu W; Shan X; Wang T; Shu Y; Liu P Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574 [TBL] [Abstract][Full Text] [Related]
20. miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells. Ba Z; Zhou Y; Yang Z; Xu J; Zhang X J Biochem; 2019 Dec; 166(6):517-527. PubMed ID: 31778188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]